Atlas Trials

TAB08 in Patients With Systemic Lupus Erythematosus (SLE), Not Adequately Controlled With Current Treatment

Clinical trial NCT02711813 · TERMINATED

Trial details

NCT number
NCT02711813
Sponsor
Theramab LLC
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Lupus Erythematosus, Systemic
Start date
2016-03-01
Primary completion
2018-05-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.